These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33744682)

  • 21. Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Bonivento C; Kambeitz-Ilankovic L; Maggioni E; Borgwardt S; Lencer R; Meisenzahl E; Kambeitz J; Ruhrmann S; Salokangas RKR; Bertolino A; Stainton A; Wenzel J; Pantelis C; Wood SJ; Upthegrove R; Koutsouleris N; Brambilla P;
    Br J Psychiatry; 2023 Oct; 223(4):485-492. PubMed ID: 37846967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between global functioning and neuropsychological predictors in subjects at high risk of psychosis or with a recent onset of depression.
    Squarcina L; Kambeitz-Ilankovic L; Bonivento C; Prunas C; Oldani L; Wenzel J; Ruef A; Dwyer D; Ferro A; Borgwardt S; Kambeitz J; Lichtenstein TK; Meisenzahl E; Pantelis C; Rosen M; Upthegrove R; Antonucci LA; Bertolino A; Lencer R; Ruhrmann S; Salokangas RRK; Schultze-Lutter F; Chisholm K; Stainton A; Wood SJ; Koutsouleris N; Brambilla P;
    World J Biol Psychiatry; 2022 Oct; 23(8):573-581. PubMed ID: 35048791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis.
    Catalan A; Tognin S; Kempton MJ; Stahl D; Salazar de Pablo G; Nelson B; Pantelis C; Riecher-Rössler A; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Ruhrmann S; Sachs G; Rutten BPF; van Os J; de Haan L; van der Gaag M; ; Valmaggia LR; McGuire P
    Psychol Med; 2022 Jun; 52(8):1569-1577. PubMed ID: 33019957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline antipsychotic prescription and short-term outcome indicators in individuals at clinical high-risk for psychosis: Findings from the Parma At-Risk Mental States (PARMS) program.
    Pelizza L; Leuci E; Quattrone E; Azzali S; Paulillo G; Pupo S; Poletti M; Raballo A; Pellegrini P; Menchetti M
    Early Interv Psychiatry; 2024 Feb; 18(2):71-81. PubMed ID: 37194411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
    Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS
    Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis.
    Hedges EP; Dickson H; Tognin S; Modinos G; Antoniades M; van der Gaag M; de Haan L; McGorry P; Pantelis C; Riecher-Rössler A; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Ruhrmann S; Sachs G; Rutten BP; van Os J; ; Valmaggia LR; McGuire P; Kempton MJ
    Schizophr Res Cogn; 2022 Jun; 28():100222. PubMed ID: 35242602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive subtypes in youth at clinical high risk for psychosis.
    Yassin W; Green J; Keshavan M; Del Re EC; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; Perkins DO; Walker EF; Woods SW; Stone WS
    medRxiv; 2024 Aug; ():. PubMed ID: 39211862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort.
    Braun A; Liu L; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J
    Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1379-1388. PubMed ID: 35113189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
    Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.
    Piskulic D; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Schizophr Res; 2016 Mar; 171(1-3):176-81. PubMed ID: 26785807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project.
    Salokangas RK; Heinimaa M; From T; Löyttyniemi E; Ilonen T; Luutonen S; Hietala J; Svirskis T; von Reventlow HG; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Ruhrmann S; Klosterkötter J;
    Eur Psychiatry; 2014 Aug; 29(6):371-80. PubMed ID: 24315804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of cognitive impairments and strengths in the early course of psychosis and depression.
    Stainton A; Chisholm K; Griffiths SL; Kambeitz-Ilankovic L; Wenzel J; Bonivento C; Brambilla P; Iqbal M; Lichtenstein TK; Rosen M; Antonucci LA; Maggioni E; Kambeitz J; Borgwardt S; Riecher-Rössler A; Andreou C; Schmidt A; Schultze-Lutter F; Meisenzahl E; Ruhrmann S; Salokangas RKR; Pantelis C; Lencer R; Romer G; Bertolino A; Upthegrove R; Koutsouleris N; Allott K; Wood SJ; ;
    Psychol Med; 2023 Oct; 53(13):5945-5957. PubMed ID: 37409883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis.
    Oomen PP; Begemann MJH; Brand BA; de Haan L; Veling W; Koops S; van Os J; Smit F; Bakker PR; van Beveren N; Boonstra N; Gülöksüz S; Kikkert M; Lokkerbol J; Marcelis M; Rosema BS; de Beer F; Gangadin SS; Geraets CNW; van 't Hag E; Haveman Y; van der Heijden I; Voppel AE; Willemse E; van Amelsvoort T; Bak M; Batalla A; Been A; van den Bosch M; van den Brink T; Faber G; Grootens KP; de Jonge M; Knegtering R; Kurkamp J; Mahabir A; Pijnenborg GHM; Staring T; Veen N; Veerman S; Wiersma S; Graveland E; Hoornaar J; Sommer IEC
    Psychol Med; 2023 Apr; 53(6):2317-2327. PubMed ID: 34664546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive Performance and Long-Term Social Functioning in Psychotic Disorder: A Three-Year Follow-Up Study.
    Simons CJ; Bartels-Velthuis AA; Pijnenborg GH;
    PLoS One; 2016; 11(4):e0151299. PubMed ID: 27082629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated neurocognitive and social-cognitive treatment for youth at clinical high risk for psychosis: Cognition for Learning and for Understanding Everyday Social Situations (CLUES).
    Friedman-Yakoobian M; Parrish EM; Thomas A; Lesser R; Gnong-Granato A; Eack S; Keshavan MS
    Schizophr Res; 2019 Jun; 208():55-59. PubMed ID: 30733169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.
    Chu AOK; Chang WC; Chan SKW; Lee EHM; Hui CLM; Chen EYH
    Psychol Med; 2019 Aug; 49(11):1929-1936. PubMed ID: 30226125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms.
    Healy C; Byrne J; Raj Suasi S; Föcking M; Mongan D; Kodosaki E; Heurich M; Cagney G; Wynne K; Bearden CE; Woods SW; Cornblatt B; Mathalon D; Stone W; Cannon TD; Addington J; Cadenhead KS; Perkins D; Jeffries C; Cotter D
    Brain Behav Immun; 2024 Mar; 117():175-180. PubMed ID: 38219978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.